These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 26905600

  • 1. Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?
    Arumugam S, Sreedhar R, Thandavarayan RA, Karuppagounder V, Watanabe K.
    Drug Discov Today; 2016 Jun; 21(6):1003-8. PubMed ID: 26905600
    [Abstract] [Full Text] [Related]

  • 2. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
    Fukushima A, Lopaschuk GD.
    Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
    [Abstract] [Full Text] [Related]

  • 3. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A, Milner K, Gupta A, Lopaschuk GD.
    Curr Pharm Des; 2015 Oct; 21(25):3654-64. PubMed ID: 26166604
    [Abstract] [Full Text] [Related]

  • 4. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
    Fukushima A, Lopaschuk GD.
    Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.
    Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD.
    Biochim Biophys Acta; 2010 Jan; 1801(1):1-22. PubMed ID: 19782765
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Metabolic therapy for heart failure].
    Loiacono F, Alberti L, Lauretta L, Puccetti P, Silipigni C, Margonato A, Fragasso G.
    Recenti Prog Med; 2014 Jan; 105(7-8):288-94. PubMed ID: 25072544
    [Abstract] [Full Text] [Related]

  • 9. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J, Zhang L, Oudit GY, Lopaschuk GD.
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [Abstract] [Full Text] [Related]

  • 10. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
    Singh KK, Shukla PC, Yanagawa B, Quan A, Lovren F, Pan Y, Wagg CS, Teoh H, Lopaschuk GD, Verma S.
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
    [Abstract] [Full Text] [Related]

  • 11. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED.
    Circ Res; 2021 May 14; 128(10):1487-1513. PubMed ID: 33983836
    [Abstract] [Full Text] [Related]

  • 12. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA, Nguyen TD, Shingu Y, Schwarzer M, Mohr FW, Schrepper A, Doenst T.
    J Thorac Cardiovasc Surg; 2010 Nov 14; 140(5):1160-7. PubMed ID: 20850803
    [Abstract] [Full Text] [Related]

  • 13. Metabolic and genetic regulation of cardiac energy substrate preference.
    Kodde IF, van der Stok J, Smolenski RT, de Jong JW.
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Jan 14; 146(1):26-39. PubMed ID: 17081788
    [Abstract] [Full Text] [Related]

  • 14. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P, Sampath H, Dobrzyn A, Miyazaki M, Ntambi JM.
    Am J Physiol Endocrinol Metab; 2008 Feb 14; 294(2):E357-64. PubMed ID: 18042664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
    Kerr M, Dodd MS, Heather LC.
    Clin Sci (Lond); 2017 Aug 15; 131(16):2079-2094. PubMed ID: 28739841
    [Abstract] [Full Text] [Related]

  • 17. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure.
    Fillmore N, Lopaschuk GD.
    Biochim Biophys Acta; 2013 Apr 15; 1833(4):857-65. PubMed ID: 22960640
    [Abstract] [Full Text] [Related]

  • 18. Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models.
    Abdurrachim D, Luiken JJ, Nicolay K, Glatz JF, Prompers JJ, Nabben M.
    Cardiovasc Res; 2015 May 01; 106(2):194-205. PubMed ID: 25765936
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C, Aasum E, Larsen TS, Montessuit C, Papageorgiou I, Pedrazzini T, Lerch R.
    J Mol Cell Cardiol; 2006 Sep 01; 41(3):459-66. PubMed ID: 16859699
    [Abstract] [Full Text] [Related]

  • 20. Metabolic toxicity of the heart: insights from molecular imaging.
    Iozzo P.
    Nutr Metab Cardiovasc Dis; 2010 Mar 01; 20(3):147-56. PubMed ID: 20031381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.